ranimustine has been researched along with Lymphoma in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (33.33) | 18.7374 |
| 1990's | 3 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoyama, T; Arai, H; Ikeda, T; Imataki, O; Ishide, K; Katsumata, N; Kume, T; Mori, M; Shiozaki, H | 1 |
| Ashizawa, M; Fujiwara, S; Hatano, K; Ito, S; Kako, S; Kanda, Y; Kawasaki, Y; Mashima, K; Minakata, D; Muroi, K; Nakano, H; Oh, I; Ohmine, K; Okazuka, K; Sato, K; Sugimoto, M; Suzuki, T; Umino, K; Yamamoto, C; Yamasaki, R | 1 |
| Chiba, S; Hasegawa, Y; Matsumura, A; Okoshi, Y; Sakamoto, N; Takano, S; Taoka, K | 1 |
| Fujimoto, N; Fujita, S; Fujitake, H; Harashima, S; Hirata, M; Hirota, Y; Horiuchi, A; Hoshino, A; Kamiya, O; Kanamaru, R; Kanayama, Y; Katoh, Y; Kawagoe, H; Kimura, K; Kitani, T; Kojima, T; Konda, C; Masaoka, T; Matsubuchi, T; Miyazaki, T; Morioka, M; Musashi, M; Nagai, K; Nagata, K; Nakamura, T; Nakao, I; Oguro, M; Ohara, K; Ohhashi, Y; Ohkubo, A; Ohno, R; Okamoto, Y; Saitoh, H; Saitoh, T; Sakai, Y; Sakurada, K; Sasada, M; Sasaki, T; Shibata, H; Takada, T; Takagi, T; Takubo, T; Taniguchi, N; Tsubaki, K; Tsubakio, T; Wakui, A; Yamada, K; Yasunaga, K; Yokoyama, M; Yonezawa, T | 1 |
| Hashimoto, S; Hasuike, T; Hirai, M; Hirai, N; Kou, KR; Ohta, K; Ohta, T; Takekawa, K; Tanaka, K; Yamane, T | 1 |
| Ashihara, E; Fujita, N; Goto, H; Hirata, T; Inaba, T; Nakagawa, M; Okawa, K; Oku, N; Shimazaki, C; Yamagata, N | 1 |
| Masaoka, T | 1 |
| Ikeda, Y; Kobayashi, M; Kobayashi, T; Ohno, R; Ohta, K; Shirakawa, S; Tanaka, I; Yamada, H; Yamada, K; Yamagata, K | 1 |
| Higuchi, A; Imamura, M; Kasai, M; Maekawa, I; Miyazaki, T; Morioka, M; Musashi, M; Ohtani, N; Saitoh, H; Sakurada, K | 1 |
2 trial(s) available for ranimustine and Lymphoma
| Article | Year |
|---|---|
[Phase II study with methyl-6[[[2-chloroethyl) nitrosoamino] carbonyl] amino]-6-deoxy-alpha-D-glucopyranoside (MCNU) in hematological malignancies].
Topics: Adult; Aged; Clinical Trials as Topic; Female; Humans; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Lymphoma; Male; Middle Aged; Multiple Myeloma; Nitrosourea Compounds | 1983 |
[Ranimustine].
Topics: Antineoplastic Agents; Busulfan; Drug Evaluation; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphoma; Nitrosourea Compounds; Polycythemia Vera; Randomized Controlled Trials as Topic; Remission Induction | 1990 |
7 other study(ies) available for ranimustine and Lymphoma
| Article | Year |
|---|---|
Comparison of Nutrition-Related Adverse Events and Clinical Outcomes Between ICE (Ifosfamide, Carboplatin, and Etoposide) and MCEC (Ranimustine, Carboplatin, Etoposide, and Cyclophosphamide) Therapies as Pretreatment for Autologous Peripheral Blood Stem C
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Energy Intake; Etoposide; Female; Humans; Ifosfamide; Lymphoma; Male; Middle Aged; Nitrosourea Compounds; Nutritional Physiological Phenomena; Peripheral Blood Stem Cell Transplantation; Survival Analysis; Transplantation, Autologous; Treatment Outcome; Young Adult | 2018 |
Retrospective evaluation of the MEAM regimen as a conditioning regimen before autologous peripheral blood stem cell transplantation for lymphoma in two centers with different dosing schedules of melphalan.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Febrile Neutropenia; Female; Humans; Lymphoma; Male; Melphalan; Middle Aged; Nausea; Nitrosourea Compounds; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Young Adult | 2016 |
A nonradiation-containing, intermediate-dose methotrexate regimen for elderly patients with primary central nervous system lymphoma.
Topics: Aged; Antimetabolites; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cytarabine; Female; Humans; Lymphoma; Male; Methotrexate; Methylprednisolone; Middle Aged; Nitrosourea Compounds; Procarbazine; Retrospective Studies | 2010 |
[Therapeutic effects of peripheral blood stem cell transplantation following combination chemotherapy using ranimustine, cytarabine, etoposide and cyclophosphamide for patients with hematological malignancies].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Lymphoma; Male; Middle Aged; Nitrosourea Compounds | 1994 |
Reconstitution of lymphocyte subsets after peripheral blood stem cell transplantation: two-color flow cytometric analysis.
Topics: Acute Disease; Adolescent; Adult; Blood Component Transfusion; Busulfan; Combined Modality Therapy; Etoposide; Female; Flow Cytometry; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunophenotyping; Leukemia, Myeloid; Leukocyte Count; Leukopenia; Lymphocyte Subsets; Lymphoma; Male; Middle Aged; Nitrosourea Compounds; Platelet Count; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1994 |
[Phase II study of methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside (MCNU)].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bone Marrow; Child; Drug Evaluation; Female; Hematologic Diseases; Humans; Leukemia; Leukemia, Myeloid; Lung Neoplasms; Lymphoma; Male; Middle Aged; Multiple Myeloma; Nitrosourea Compounds; Polycythemia Vera; Stomach Neoplasms; Thrombocytopenia | 1985 |
[Phase II study with methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside (MCNU) in hematological malignancies].
Topics: Adult; Aged; Antineoplastic Agents; Drug Administration Schedule; Drug Evaluation; Female; Humans; Leukemia, Myeloid; Lymphoma; Male; Middle Aged; Multiple Myeloma; Nitrosourea Compounds; Polycythemia | 1985 |